Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases

American Journal of Pathology

Volumn 186, Issue 1, 2016, Pages 185-198

  Bilousova, Tina ^a   Miller, Carol A ^c   Poon, Wayne W ^d   Vinters, Harry V ^b   Corrada, Maria ^d,e   Kawas, Claudia ^d,e   Hayden, Eric Y ^a,b   Teplow, David B ^a,b   Glabe, Charles ^d   Albay, Ricardo ^d   Cole, Gregory M ^a,b,f   Teng, Edmond ^a,b,f   Gylys, Karen H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; HYPERPHOSPHORYLATED TAU; OLIGOMER; PHOSPHOPROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PARIETAL CORTEX; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RAT; SINGLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY.; SYNAPSE; VERY ELDERLY; ANIMAL; BRAIN; CONFOCAL MICROSCOPY; DISEASE MODEL; PATHOLOGY; PHOSPHORYLATION; TRANSGENIC RAT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; RATS; RATS, TRANSGENIC; SYNAPSES; TAU PROTEINS;

EID: 84955453118     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.09.018     Document Type: Article

References (87)

1. M.E. Larson, and S.E. Lesne Soluble Abeta oligomer production and toxicity J Neurochem 120 Suppl 1 2012 125 139
2. F. Hefti, W.F. Goure, J. Jerecic, K.S. Iverson, P.A. Walicke, and G.A. Krafft The case for soluble Abeta oligomers as a drug target in Alzheimer's disease Trends Pharmacol Sci 34 2013 261 266
3. P.V. Arriagada, J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 42 1992 631 639
4. L.M. Bierer, P.R. Hof, D.P. Purohit, L. Carlin, J. Schmeidler, K.L. Davis, and D.P. Perl Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease Arch Neurol 52 1995 81 88
5. P. Giannakopoulos, F.R. Herrmann, T. Bussiere, C. Bouras, E. Kovari, D.P. Perl, J.H. Morrison, G. Gold, and P.R. Hof Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease Neurology 60 2003 1495 1500
6. T. Gomez-Isla, J.L. Price, D.W. McKeel Jr., J.C. Morris, J.H. Growdon, and B.T. Hyman Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease J Neurosci 16 1996 4491 4500
7. B.T. Hyman, K. Marzloff, and P.V. Arriagada The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution J Neuropathol Exp Neurol 52 1993 594 600
8. M. Ingelsson, H. Fukumoto, K.L. Newell, J.H. Growdon, E.T. Hedley-Whyte, M.P. Frosch, M.S. Albert, B.T. Hyman, and M.C. Irizarry Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology 62 2004 925 931
9. B.J. Cummings, and C.W. Cotman Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity Lancet 346 1995 1524 1528
10. R.J. Defigueiredo, B.J. Cummings, P.Y. Mundkur, and C.W. Cotman Color image analysis in neuroanatomical research: application to senile plaque subtype quantification in Alzheimer's disease Neurobiol Aging 16 1995 211 223
11. S.M. Kanne, D.A. Balota, M. Storandt, D.W. McKeel Jr., and J.C. Morris Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later Neurology 50 1998 979 985
12. V. Haroutunian, D.P. Perl, D.P. Purohit, D. Marin, K. Khan, M. Lantz, K.L. Davis, and R.C. Mohs Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease Arch Neurol 55 1998 1185 1191
13. D.J. Selkoe Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behav Brain Res 192 2008 106 113
14. G. Mairet-Coello, J. Courchet, S. Pieraut, V. Courchet, A. Maximov, and F. Polleux The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation Neuron 78 2013 94 108
15. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
16. M.A. Chabrier, M. Blurton-Jones, A.A. Agazaryan, J.L. Nerhus, H. Martinez-Coria, and F.M. LaFerla Soluble abeta promotes wild-type tau pathology in vivo J Neurosci 32 2012 17345 17350
17. L.M. Ittner, Y.D. Ke, F. Delerue, M. Bi, A. Gladbach, J. van Eersel, H. Wolfing, B.C. Chieng, M.J. Christie, I.A. Napier, A. Eckert, M. Staufenbiel, E. Hardeman, and J. Gotz Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models Cell 142 2010 387 397
18. S.T. DeKosky, S.W. Scheff, and S.D. Styren Structural correlates of cognition in dementia: quantification and assessment of synapse change Neurodegeneration 5 1996 417 421
19. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann Neurol 27 1990 457 464
20. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
21. E. Masliah, M. Mallory, L. Hansen, R. DeTeresa, M. Alford, and R. Terry Synaptic and neuritic alterations during the progression of Alzheimer's disease Neurosci Lett 174 1994 67 72
22. R.H. Takahashi, E. Capetillo-Zarate, M.T. Lin, T.A. Milner, and G.K. Gouras Co-occurrence of Alzheimer's disease beta-amyloid and tau pathologies at synapses Neurobiol Aging 31 2010 1145 1152
23. R.H. Takahashi, T.A. Milner, F. Li, E.E. Nam, M.A. Edgar, H. Yamaguchi, M.F. Beal, H. Xu, P. Greengard, and G.K. Gouras Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology Am J Pathol 161 2002 1869 1879
24. T. Ma, and E. Klann Amyloid beta: linking synaptic plasticity failure to memory disruption in Alzheimer's disease J Neurochem 120 Suppl 1 2012 140 148
25. J.R. Cirrito, K.A. Yamada, M.B. Finn, R.S. Sloviter, K.R. Bales, P.C. May, D.D. Schoepp, S.M. Paul, S. Mennerick, and D.M. Holtzman Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo Neuron 48 2005 913 922
26. S. Sokolow, K.M. Henkins, T. Bilousova, C.A. Miller, H.V. Vinters, W. Poon, G.M. Cole, and K.H. Gylys AD synapses contain abundant Abeta monomer and multiple soluble oligomers, including a 56-kDa assembly Neurobiol Aging 33 2012 1545 1555
27. K.M. Henkins, S. Sokolow, C.A. Miller, H.V. Vinters, W. Poon, L.B. Cornwell, T. Saing, and K.H. Gylys Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses Brain Pathol 22 2012 826 833
28. H.C. Tai, A. Serrano-Pozo, T. Hashimoto, M.P. Frosch, T.L. Spires-Jones, and B.T. Hyman The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system Am J Pathol 181 2012 1426 1435
29. C.A. Lasagna-Reeves, D.L. Castillo-Carranza, U. Sengupta, A.L. Clos, G.R. Jackson, and R. Kayed Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice Mol Neurodegener 6 2011 39
30. S. Maeda, N. Sahara, Y. Saito, S. Murayama, A. Ikai, and A. Takashima Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease Neurosci Res 54 2006 197 201
31. K.R. Patterson, C. Remmers, Y. Fu, S. Brooker, N.M. Kanaan, L. Vana, S. Ward, J.F. Reyes, K. Philibert, M.J. Glucksman, and L.I. Binder Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease J Biol Chem 286 2011 23063 23076
32. F. Yang, K. Mak, H.V. Vinters, S.A. Frautschy, and G.M. Cole Monoclonal antibody to the C-terminus of beta-amyloid Neuroreport 5 1994 2117 2120
33. J.A. Fein, S. Sokolow, C.A. Miller, H.V. Vinters, F. Yang, G.M. Cole, and K.H. Gylys Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes Am J Pathol 172 2008 1683 1692
34. D.G. Flood, Y.G. Lin, D.M. Lang, S.P. Trusko, J.D. Hirsch, M.J. Savage, R.W. Scott, and D.S. Howland A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition Neurobiol Aging 30 2009 1078 1090
35. E. Teng, V. Kepe, S.A. Frautschy, J. Liu, N. Satyamurthy, F. Yang, P.P. Chen, G.B. Cole, M.R. Jones, S.C. Huang, D.G. Flood, S.P. Trusko, G.W. Small, G.M. Cole, and J.R. Barrio [F-18]FDDNP microPET imaging correlates with brain Abeta burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Abeta antibody treatment Neurobiol Dis 43 2011 565 575
36. L. Liu, I.J. Orozco, E. Planel, Y. Wen, A. Bretteville, P. Krishnamurthy, L. Wang, M. Herman, H. Figueroa, W.H. Yu, O. Arancio, and K. Duff A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment Neurobiol Dis 31 2008 46 57
37. K.H. Gylys, J.A. Fein, F. Yang, and G.M. Cole Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex Cytometry A 60 2004 90 96
38. C. Rosensweig, K. Ono, K. Murakami, D.K. Lowenstein, G. Bitan, and D.B. Teplow Preparation of stable amyloid beta-protein oligomers of defined assembly order Methods Mol Biol 849 2012 23 31
39. G.P. Lim, F. Yang, T. Chu, P. Chen, W. Beech, B. Teter, T. Tran, O. Ubeda, K.H. Ashe, S.A. Frautschy, and G.M. Cole Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease J Neurosci 20 2000 5709 5714
40. P.R. Dunkley, P.E. Jarvie, and P.J. Robinson A rapid Percoll gradient procedure for preparation of synaptosomes Nat Protoc 3 2008 1718 1728
41. B.G. Wilhelm, S. Mandad, S. Truckenbrodt, K. Krohnert, C. Schafer, B. Rammner, S.J. Koo, G.A. Classen, M. Krauss, V. Haucke, H. Urlaub, and S.O. Rizzoli Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins Science 344 2014 1023 1028
42. K.H. Gylys, J.A. Fein, F. Yang, C.A. Miller, and G.M. Cole Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex Neurobiol Aging 28 2007 8 17
43. K.H. Gylys, J.A. Fein, A.M. Tan, and G.M. Cole Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals J Neurochem 84 2003 1442 1451
44. S. Sokolow, K.M. Henkins, I.A. Williams, H.V. Vinters, I. Schmid, G.M. Cole, and K.H. Gylys Isolation of synaptic terminals from Alzheimer's disease cortex Cytometry A 81 2012 248 254
45. K.L. Youmans, L.M. Tai, T. Kanekiyo, W.B. Stine Jr., S.C. Michon, E. Nwabuisi-Heath, A.M. Manelli, Y. Fu, S. Riordan, W.A. Eimer, L. Binder, G. Bu, C. Yu, D.M. Hartley, and M.J. LaDu Intraneuronal Abeta detection in 5xFAD mice by a new Abeta-specific antibody Mol Neurodegener 7 2012 8
46. A. Hatami, R. Albay 3rd, S. Monjazeb, S. Milton, and C. Glabe Monoclonal antibodies against Abeta42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain J Biol Chem 289 2014 32131 32143
47. K.H. Gylys, J.A. Fein, F. Yang, D.J. Wiley, C.A. Miller, and G.M. Cole Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence Am J Pathol 165 2004 1809 1817
48. D.R. Thal, U. Rub, M. Orantes, and H. Braak Phases of A beta-deposition in the human brain and its relevance for the development of AD Neurology 58 2002 1791 1800
49. S.L. Bernstein, N.F. Dupuis, N.D. Lazo, T. Wyttenbach, M.M. Condron, G. Bitan, D.B. Teplow, J.E. Shea, B.T. Ruotolo, C.V. Robinson, and M.T. Bowers Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease Nat Chem 1 2009 326 331
50. S.E. Lesne, M.A. Sherman, M. Grant, M. Kuskowski, J.A. Schneider, D.A. Bennett, and K.H. Ashe Brain amyloid-beta oligomers in ageing and Alzheimer's disease Brain 136 2013 1383 1398
51. T.J. Esparza, H. Zhao, J.R. Cirrito, N.J. Cairns, R.J. Bateman, D.M. Holtzman, and D.L. Brody Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls Ann Neurol 73 2013 104 119
52. K.L. Youmans, L.M. Tai, E. Nwabuisi-Heath, L. Jungbauer, T. Kanekiyo, M. Gan, J. Kim, W.A. Eimer, S. Estus, G.W. Rebeck, E.J. Weeber, G. Bu, C. Yu, and M.J. Ladu APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease J Biol Chem 287 2012 41774 41786
53. K.A. Bruggink, W. Jongbloed, E.A. Biemans, R. Veerhuis, J.A. Claassen, H.B. Kuiperij, and M.M. Verbeek Amyloid-beta oligomer detection by ELISA in cerebrospinal fluid and brain tissue Anal Biochem 433 2013 112 120
54. T. Kasai, T. Tokuda, M. Taylor, M. Kondo, D.M. Mann, P.G. Foulds, M. Nakagawa, and D. Allsop Correlation of Abeta oligomer levels in matched cerebrospinal fluid and serum samples Neurosci Lett 551 2013 17 22
55. T. Yang, S. Hong, T. O'Malley, R.A. Sperling, D.M. Walsh, and D.J. Selkoe New ELISAs with high specificity for soluble oligomers of amyloid beta-protein detect natural Abeta oligomers in human brain but not CSF Alzheimers Dement 9 2013 99 112
56. D. McLean, M.J. Cooke, R. Albay 3rd, C. Glabe, and M.S. Shoichet Positron emission tomography imaging of fibrillar parenchymal and vascular amyloid-beta in TgCRND8 mice ACS Chem Neurosci 4 2013 613 623
57. R. Kayed, I. Canto, L. Breydo, S. Rasool, T. Lukacsovich, J. Wu, R. Albay 3rd, A. Pensalfini, S. Yeung, E. Head, J.L. Marsh, and C. Glabe Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Abeta oligomers Mol Neurodegener 5 2010 57
58. K.J. Kopeikina, M. Polydoro, H.C. Tai, E. Yaeger, G.A. Carlson, R. Pitstick, B.T. Hyman, and T.L. Spires-Jones Synaptic alterations in the rTg4510 mouse model of tauopathy J Comp Neurol 521 2013 1334 1353
59. A.M. Pooler, M. Polydoro, S.K. Wegmann, R. Pitstick, K.R. Kay, L. Sanchez, G.A. Carlson, T. Gomez-Isla, M.W. Albers, T.L. Spires-Jones, and B.T. Hyman Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology J Comp Neurol 521 2013 4236 4248
60. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, S. Rothacher, B. Ledermann, K. Burki, P. Frey, P.A. Paganetti, C. Waridel, M.E. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, and B. Sommer Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc Natl Acad Sci U S A 94 1997 13287 13292
61. D. Moechars, I. Dewachter, K. Lorent, D. Reverse, V. Baekelandt, A. Naidu, I. Tesseur, K. Spittaels, C.V. Haute, F. Checler, E. Godaux, B. Cordell, and F. Van Leuven Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain J Biol Chem 274 1999 6483 6492
62. H.J. Aizenstein, R.D. Nebes, J.A. Saxton, J.C. Price, C.A. Mathis, N.D. Tsopelas, S.K. Ziolko, J.A. James, B.E. Snitz, P.R. Houck, W. Bi, A.D. Cohen, B.J. Lopresti, S.T. DeKosky, E.M. Halligan, and W.E. Klunk Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 2008 1509 1517
63. M.A. Mintun, G.N. Larossa, Y.I. Sheline, C.S. Dence, S.Y. Lee, R.H. Mach, W.E. Klunk, C.A. Mathis, S.T. DeKosky, and J.C. Morris [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 67 2006 446 452
64. C.C. Rowe, S. Ng, U. Ackermann, S.J. Gong, K. Pike, G. Savage, T.F. Cowie, K.L. Dickinson, P. Maruff, D. Darby, C. Smith, M. Woodward, J. Merory, H. Tochon-Danguy, G. O'Keefe, W.E. Klunk, C.A. Mathis, J.C. Price, C.L. Masters, and V.L. Villemagne Imaging beta-amyloid burden in aging and dementia Neurology 68 2007 1718 1725
65. K.P. Riley, D.A. Snowdon, M.F. Desrosiers, and W.R. Markesbery Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study Neurobiol Aging 26 2005 341 347
66. T. Kanekiyo, J. Zhang, Q. Liu, C.C. Liu, L. Zhang, and G. Bu Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake J Neurosci 31 2011 1644 1651
67. G.K. Gouras, K. Willen, and D. Tampellini Critical role of intraneuronal Abeta in Alzheimer's disease: technical challenges in studying intracellular Abeta Life Sci 91 2012 1153 1158
68. J.R. Cirrito, J.E. Kang, J. Lee, F.R. Stewart, D.K. Verges, L.M. Silverio, G. Bu, S. Mennerick, and D.M. Holtzman Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo Neuron 58 2008 42 51
69. A.W. Bero, P. Yan, J.H. Roh, J.R. Cirrito, F.R. Stewart, M.E. Raichle, J.M. Lee, and D.M. Holtzman Neuronal activity regulates the regional vulnerability to amyloid-beta deposition Nat Neurosci 14 2011 750 756
70. D.S. Yang, P. Stavrides, P.S. Mohan, S. Kaushik, A. Kumar, M. Ohno, S.D. Schmidt, D. Wesson, U. Bandyopadhyay, Y. Jiang, M. Pawlik, C.M. Peterhoff, A.J. Yang, D.A. Wilson, P. St George-Hyslop, D. Westaway, P.M. Mathews, E. Levy, A.M. Cuervo, and R.A. Nixon Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits Brain 134 2011 258 277
71. A.M. Cataldo, J.L. Barnett, S.A. Berman, J. Li, S. Quarless, S. Bursztajn, C. Lippa, and R.A. Nixon Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system Neuron 14 1995 671 680
72. A.M. Cataldo, D.J. Hamilton, J.L. Barnett, P.A. Paskevich, and R.A. Nixon Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease J Neurosci 16 1996 186 199
73. D.A. Bennett, S.E. Arnold, M.J. Valenzuela, C. Brayne, and J.A. Schneider Cognitive and social lifestyle: links with neuropathology and cognition in late life Acta Neuropathol 127 2014 137 150
74. J.T. Yu, L. Tan, and J. Hardy Apolipoprotein E in Alzheimer's disease: an update Annu Rev Neurosci 37 2014 79 100
75. B.G. Perez-Nievas, T.D. Stein, H.C. Tai, O. Dols-Icardo, T.C. Scotton, I. Barroeta-Espar, L. Fernandez-Carballo, E.L. de Munain, J. Perez, M. Marquie, A. Serrano-Pozo, M.P. Frosch, V. Lowe, J.E. Parisi, R.C. Petersen, M.D. Ikonomovic, O.L. Lopez, W. Klunk, B.T. Hyman, and T. Gomez-Isla Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology Brain 136 2013 2510 2526
76. N.L. Bjorklund, L.C. Reese, V.M. Sadagoparamanujam, V. Ghirardi, R.L. Woltjer, and G. Taglialatela Absence of amyloid beta oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology Mol Neurodegener 7 2012 23
77. R.M. Koffie, M. Meyer-Luehmann, T. Hashimoto, K.W. Adams, M.L. Mielke, M. Garcia-Alloza, K.D. Micheva, S.J. Smith, M.L. Kim, V.M. Lee, B.T. Hyman, and T.L. Spires-Jones Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques Proc Natl Acad Sci U S A 106 2009 4012 4017
78. N. Kfoury, B.B. Holmes, H. Jiang, D.M. Holtzman, and M.I. Diamond Trans-cellular propagation of Tau aggregation by fibrillar species J Biol Chem 287 2012 19440 19451
79. A. de Calignon, M. Polydoro, M. Suarez-Calvet, C. William, D.H. Adamowicz, K.J. Kopeikina, R. Pitstick, N. Sahara, K.H. Ashe, G.A. Carlson, T.L. Spires-Jones, and B.T. Hyman Propagation of tau pathology in a model of early Alzheimer's disease Neuron 73 2012 685 697
80. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, and J.D. Buxbaum Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA 283 2000 1571 1577
81. H. Braak, and E. Braak Staging of Alzheimer's disease-related neurofibrillary changes Neurobiol Aging 16 1995 271 278 discussion 278-84
82. F. Clavaguera, T. Bolmont, R.A. Crowther, D. Abramowski, S. Frank, A. Probst, G. Fraser, A.K. Stalder, M. Beibel, M. Staufenbiel, M. Jucker, M. Goedert, and M. Tolnay Transmission and spreading of tauopathy in transgenic mouse brain Nat Cell Biol 11 2009 909 913
83. S. Dujardin, K. Lecolle, R. Caillierez, S. Begard, N. Zommer, C. Lachaud, S. Carrier, N. Dufour, G. Auregan, J. Winderickx, P. Hantraye, N. Deglon, M. Colin, and L. Buee Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies Acta Neuropathol Commun 2 2014 14
84. M. Jin, N. Shepardson, T. Yang, G. Chen, D. Walsh, and D.J. Selkoe Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration Proc Natl Acad Sci U S A 108 2011 5819 5824
85. L.C. Walker, M.I. Diamond, K.E. Duff, and B.T. Hyman Mechanisms of protein seeding in neurodegenerative diseases JAMA Neurol 70 2013 304 310
86. L.M. Ittner, and J. Gotz Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease Nat Rev Neurosci 12 2011 65 72
87. C.M. Hernandez, I. Cortez, Z. Gu, J.O. Colon-Saez, P.W. Lamb, M. Wakamiya, J.L. Yakel, and K.T. Dineley Research tool: validation of floxed alpha7 nicotinic acetylcholine receptor conditional knockout mice using in vitro and in vivo approaches J Physiol 592 2014 3201 3214